NYSE:ANVS | Free Cash Flow | Annovis Bio, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$9.01M
2025-12-31-$8.93M
2025-03-31-$8.1M
2024-12-31-$8.29M
2024-03-31-$7.03M
2023-12-31-$9.36M
2023-03-31-$11.63M
2022-12-31-$3.61M
2022-03-31-$3.02M
2021-12-31-$1.77M
2021-03-31-$2.47M
2020-12-31-$765,949.00
2020-03-31-$970,405.00
2019-12-31-$52,528.00
2019-03-31-$228,739.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$25.62M
2024-12-31-$21.89M
2023-12-31-$39.97M
2022-12-31-$17.31M
2021-12-31-$9.13M
2020-12-31-$3.97M
2019-12-31-$476,542.00